Health care burden of dyspepsia among nonvalvular atrial fibrillation patients.
CONCLUSIONS: NVAF patients with dyspepsia experienced more all-cause hospitalizations and required more outpatient medical services, all associated with greater expenditures than NVAF patients without dyspepsia. Additionally, dyspepsia may be a barrier to warfarin use among NVAF patients.
PMID: 24684644 [PubMed - in process]
Source: Journal of Managed Care Pharmacy - Category: Drugs & Pharmacology Tags: J Manag Care Pharm Source Type: research
More News: Atrial Fibrillation | Coumadin | Databases & Libraries | Drugs & Pharmacology | Dyspepsia | Health Management | Hospital Management | Insurance | Managed Care | Medicare | Stroke | Study | Warfarin